First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when giv...

por Lindgren, Line M., Tingskov, Pernille N., Justesen, Annette H., Nedergaard, Bettina S., Olsen, Klaus J., Andreasen, Lars V., Kromann, Ingrid, Sørensen, Charlotte, Dietrich, Jes, Thierry-Carstensen, Birgit
Publicado 2017

Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in t...

por Rivera, Luis, Pedersen, Rasmus S, Peña, Lourdes, Olsen, Klaus J, Andreasen, Lars V, Kromann, Ingrid, Nielsen, Pernille I, Sørensen, Charlotte, Dietrich, Jes, Bandyopadhyay, Ananda S, Thierry-Carstensen, Birgit
Publicado 2017

Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin

por Lewis, David J. M., Huo, Zhiming, Barnett, Susan, Kromann, Ingrid, Giemza, Rafaela, Galiza, Eva, Woodrow, Maria, Thierry-Carstensen, Birgit, Andersen, Peter, Novicki, Deborah, Del Giudice, Giuseppe, Rappuoli, Rino
Publicado 2009

Availability and use of Standards in vaccine development

por Avumegah, Michael Selorm, Mattiuzzo, Giada, Särnefält, Anna, Page, Mark, Makar, Karen, Lathey, Janet, Kim, June, Yimer, Solomon Abebe, Craig, Danielle, Knezevic, Ivana, Bernasconi, Valentina, Kristiansen, Paul A., Kromann, Ingrid
Publicado 2023

A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area

por Hussein, Jemal, Zewdie, Martha, Yamuah, Lawrence, Bedru, Ahmed, Abebe, Markos, Dagnew, Alemnew F., Chanyalew, Menberework, Yohannes, Asfawesen G., Ahmed, Jemal, Engers, Howard, Doherty, T. Mark, Bang, Peter, Kromann, Ingrid, Hoff, Søren T., Aseffa, Abraham
Publicado 2018

Safety and Immunogenicity of H1/IC31®, an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm(3): A Phase II, Multi-Centre,...

por Reither, Klaus, Katsoulis, Lynn, Beattie, Trevor, Gardiner, Nicolene, Lenz, Nicole, Said, Khadija, Mfinanga, Elirehema, Pohl, Christian, Fielding, Katherine L., Jeffery, Hannah, Kagina, Benjamin M., Hughes, Elisabeth J., Scriba, Thomas J., Hanekom, Willem A., Hoff, Søren T., Bang, Peter, Kromann, Ingrid, Daubenberger, Claudia, Andersen, Peter, Churchyard, Gavin J.
Publicado 2014

A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolesce...

por Bekker, Linda-Gail, Dintwe, One, Fiore-Gartland, Andrew, Middelkoop, Keren, Hutter, Julia, Williams, Anthony, Randhawa, April K., Ruhwald, Morten, Kromann, Ingrid, Andersen, Peter L., DiazGranados, Carlos A., Rutkowski, Kathryn T., Tait, Dereck, Miner, Maurine D., Andersen-Nissen, Erica, De Rosa, Stephen C., Seaton, Kelly E., Tomaras, Georgia D., McElrath, M. Juliana, Ginsberg, Ann, Kublin, James G.
Publicado 2020

Prevention of Infection with Mycobacterium tuberculosis by H4:IC31® Vaccination or BCG Revaccination in Adolescents

por Nemes, Elisa, Geldenhuys, Hennie, Rozot, Virginie, Tucker Rutkowski, Kathryn, Ratangee, Frances, Bilek, Nicole, Mabwe, Simbarashe, Makhethe, Lebohang, Erasmus, Mzwandile, Toefy, Asma, Mulenga, Humphrey, Hanekom, Willem A., Self, Steven G., Bekker, Linda-Gail, Ryall, Robert, Gurunathan, Sanjay, DiazGranados, Carlos A., Andersen, Peter, Kromann, Ingrid, Evans, Thomas, Ellis, Ruth D., Landry, Bernard, Hokey, David A., Hopkins, Robert, Ginsberg, Ann M., Scriba, Thomas J., Hatherill, Mark
Publicado 2018